Skip to main content
SpringerLink
Log in

Krankheiten der Leber

  • Chapter
Therapie von Leber- und Gallekrankheiten

  • 19 Accesses

Zusammenfassung

Die Einteilung der akuten Virushepatitiden erfolgt nach den verschiedenen bekannten Erregern. Man unterscheidet Viren mit einem hohen hepatischen Tropismus [Hepatitis-A-, B-, C-, D-, E-, (fraglich) G-Virus] von Virusinfektionen mit hepatischer Beteiligung (Zytomegalie-, Epstein-Barr-, Herpes-simplex-, Varizella-zoster-Virus u. a.). Letztere sowie die vorwiegend enteral übertragenen Hepatitis-A- und -E-Virusinfektionen verlaufen selbstlimitierend. Chronisch verlaufende Infektionen sind durch Hepatitis-B-, Hepatitis-D-, Hepatitis-C- und Hepatitis-G-Viren bedingt (Tabelle 1.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Blum HE, Maier KP, Strohmeyer G für das Virushepatitis-Panel (1995) Aktuelle Therapie der chronischen Virushepatitis. Dtsch Med Wochenschr 120: 295–300

    Article  PubMed  CAS  Google Scholar 

  • Dienstag JL, Perillo P, Schiff E, Batholomew M, Vicary C, Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333: 1657–1661

    Article  PubMed  CAS  Google Scholar 

  • Farci P, Mandas A, Coiana A et al. (1994) Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 330: 88–94

    Article  PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Di Biscegli AM, Waggoner JG, Park Y (1993) Inteferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 104: 1116–1121

    PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Di Bisceglie AM (1997) The treatment of chronic viral hepatitis. N Engl J Med 336: 347–356

    Article  PubMed  CAS  Google Scholar 

  • Kurstak E (1993) Viral hepatitis. Current status and issues. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Lemon SM, Thomas DL (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336:196–204 Maier KP ( 1995 ) Hepatitis - Hepatitisfolgen. Praxis der Diagnostik, Therapie und Prophylaxe akuter und chronischer Lebererkrankungen. Thieme, Stuttgart New York

    Google Scholar 

  • Meyer zum Büschenfelde KH (1989) Hepatologie in Klinik und Praxis. Grundlagen, Diagnostik und Therapie. Thieme, Stuttgart New York

    Google Scholar 

  • Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP (1996) Metaanalysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepatology 24: 778–789

    Google Scholar 

  • Schreiber GB, Busch M, Kleinman M, Korelitz J J (1996) The risk of transfusion-transmitted viral infections. N Engl J Med 334: 1685–1690

    Article  PubMed  CAS  Google Scholar 

  • Sherlock S, Dooley J (1993) Diseases of the liver and biliary system. Blackwell Scientific Publications, Oxford

    Google Scholar 

  • Simons JN, Pilot-Matias TJ, Leary TP et al. (1995) Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sei USA 92: 3401–3405

    Article  CAS  Google Scholar 

  • Strader DB, Seeff LB (1996) Immunization for viral hepatitis. Curr Opin Gastroenterol 13: 224–230

    Article  Google Scholar 

  • Wong DKH, Cheung AM, O’ourke K, Naylor CD, Detsky AS, Heatheote J (1993) Effect of alpha-interferon treatment in patients with hepatitis B-antigen-positive chronic hepatitis B: a metaanalysis. Ann Intern Med 119: 312–323

    PubMed  CAS  Google Scholar 

  • Zeuzem S, Herrmann G, Roth WK (1995) Virushepatitis C. Z Gastroenterol 33: 117–132

    PubMed  CAS  Google Scholar 

  • Brodt HR, Helm EB, Kamps BS (1995) AIDS 1995. Diagnostik und Therapie HIV-assoziierter Erkrankungen. Steinhäuser, Wuppertal

    Google Scholar 

  • Eisenstein BI (1990) New opportunistic infections - more opportunities. N Engl J Med 323: 1625–1627

    Article  PubMed  CAS  Google Scholar 

  • Gazzard BG (1994) Prophylaxe HIV-assoziierter opportunistischer Infektionen. Internist 35: 901–905

    PubMed  CAS  Google Scholar 

  • Horsburgh CR (1991) Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324: 1332–1338

    Article  PubMed  Google Scholar 

  • Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP et al. (1997) Low dose compared with standard-dose m-BACOD chemotherapy for Non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection. N Engl J Med 336: 1641–1648

    Article  PubMed  CAS  Google Scholar 

  • Relman DA, Falkow S, LeBoit PE (1991) The organisms causing bacillary angiomatosis, pe- liosis hepatis, and fever and bacteriemia in immunocompromized patients. N Engl J Med 324: 1514–1517

    PubMed  CAS  Google Scholar 

  • Rockstroh JK, Spengler U, Reichel C, Sauerbruch T (1995) Gastrointestinale Manifestationen. In: Jäger H (Hrsg) AIDS und HIV-Infektionen: Diagnostik, Klinik, Behandlung; Handbuch und Atlas für Klinik und Praxis. Ecomed, Landsberg a. L., V–3: 1–63

    Google Scholar 

  • Rockstroh JK, Spengler U, Sauerbruch T (1995) Therapie der Virushepatitis bei HIV-Infizierten. Dtsch Med Wochenschr 120: 1705–1708

    Article  PubMed  CAS  Google Scholar 

  • Small PM, Schechter GF, Goodman PC, Sande MA, Caisson RE, Hopewell PC (1991) Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 324: 289–294

    Article  PubMed  CAS  Google Scholar 

  • Berg CL, Gollan JL (1992) Primary biliary cirrhosis: new therapeutic directions. Scand J Gastroent 27 (Suppl.): 43–49

    Article  Google Scholar 

  • Berg PA, Klein R (1995) Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited. Liver 15: 281–292

    PubMed  CAS  Google Scholar 

  • David R, Kurtz W, Strohm WD, Leuschner U (1985) Die Wirkung von Ursodeoxycholsäure bei chronischen Leberkrankheiten. Z Gastroenterol 23: 420–425

    Google Scholar 

  • Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in ar-antitrypsin deficiency. N Engl J Med 314: 736–739

    Article  PubMed  CAS  Google Scholar 

  • Heathcote FJ, Lindor KD, Poupon RE et al. (1995) Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis (Abstr.). Dig Dis Week, May 14–17

    Google Scholar 

  • Jones EA, Bergassa NV (1996) Why do cholestatic patients itch? Gut 38:644–645 Kaplan MM (1987) Primary biliary cirrhosis. Adv Intern Med 32: 359–378

    Google Scholar 

  • Laurin JM, Lindor KD (1994) Primary biliary cirrhosis. Dig Dis Sci 12: 331–350

    Article  CAS  Google Scholar 

  • Leuschner U, Güldütuna S, Imhof M, Hübner K, Benjaminov A, Leuschner M (1994) Effects of ursodeoxycholic acid after 4 to 12 years therapy in early and late stages of primary biliary cirrhosis. J Hepatol 21: 624–633

    Article  PubMed  CAS  Google Scholar 

  • Markus BH, Dickson ER, Grambsch PM et al. (1989) Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 320: 1709–1713

    Article  PubMed  CAS  Google Scholar 

  • Narumi S, Roberts JP, Emond JC, Lake J, Asher L (1995) Liver transplantation for sclerosing cholangitis. Hepatology 22: 451–457

    Article  PubMed  CAS  Google Scholar 

  • Popper H, Schaffner F (1979) Nonsuppurative destructive chronic cholangitis and chronic hepatitis. In: Popper H, Schaffner F (Hrsg) Progress in liver diseases. Grune u. Stratton, New York, vol 3, S 336–342

    Google Scholar 

  • Psacharopoulos HT, Mowat AP (1983) The liver and biliary system. In: Hodson ME, Normann AP, Batten JC (Hrsg) Cystic fibrosis. Balliere & Tindall, London, S 164–170

    Google Scholar 

  • Stiehl A (1996) Treatment of primary biliary liver diseases. In: Fromm H, Leuschner U (Hrsg) Bile acids - cholestasis - gallstones. Advances in basic and clinical bile acid research. Kluwer Acad Publ, Dordrecht, Boston, London, S 269–274

    Google Scholar 

  • Adams PC, Speechley M, Rertesz AN (1991) Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 101: 368–372

    PubMed  CAS  Google Scholar 

  • Crawford DH, Halliday JW (1991) Current concepts in rational therapy for hemochromatosis. Drugs 41: 875–882

    Article  PubMed  CAS  Google Scholar 

  • Deugnier YM, Guyader D, Cantock L et al. (1993) Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenic study of 54 cases. Gastroenterology 104: 228–234

    PubMed  CAS  Google Scholar 

  • Feder JN, Gnirke A, Thomas W et al. (1996) A novel MHC class like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399–408

    Article  PubMed  CAS  Google Scholar 

  • Halliday JW (1992) The regulation of iron absorption: one more piece in the puzzle. Gastroenterology 326: 1071–1073

    Google Scholar 

  • Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256–1262

    Article  PubMed  CAS  Google Scholar 

  • Olivieri NF, Koren G, Hermann C et al. (1990) Comparison of oral iron chelator LI and desferrioxamin in iron-overload patients. Lancet 336: 1275–1279

    Article  PubMed  CAS  Google Scholar 

  • Powell LW, Jazwinska E, Halliday JW (1994) Primary iron overload. In: Brock JH, Halliday JW, Pippard M, Powell LW (Hrsg) Iron Metabolism in Health and Disease. WB Saunders, Philadelphia

    Google Scholar 

  • Stremmel W, Niederau C, Strohmeyer G (1993) Diagnose der primären Hämochromatose. Dtsch Med Wochenschr 118: 227–230

    Article  PubMed  CAS  Google Scholar 

  • Stremmel W, Niederau C, Strohmeyer G (1993) Therapie der primären Hämochromatose. Dtsch Med Wochenschr 118: 267–270

    Article  PubMed  CAS  Google Scholar 

  • Buscher HP (1995) Wilson Krankheit. In: Gerok W, Blum HE (Hrsg) Hepatologie. Urban & Schwarzenberg, München, S 495–507

    Google Scholar 

  • Davis W, Chowrimootoo GFE, Seymour CA (1996) Defective biliary copper excretion in Wilson’s disease: the role of caeruloplasmin. Europ J Clin Invest 25: 893–901

    Article  Google Scholar 

  • Lipsky MA, Gollan JL (1987) Treatment of Wilson’s disease. In: D-penicillamine we trust -what about zinc? Hepatology 7: 573–575

    Google Scholar 

  • Probst T, Probst A, Judmaier G, Vogel W (1996) Morbus Wilson. Dtsch Med Wochenschr 121: 280–284

    Google Scholar 

  • Sternlieb I, Scheinberg ICH (1968) Prevention of Wilson’s disease in asymptomatic patients. N Engl J Med 278: 352–358

    Article  PubMed  CAS  Google Scholar 

  • Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G (1991) Clinical presentation, treatment and survival in 51 patients with Wilson’s disease. Ann intern Med 115: 720–726

    PubMed  CAS  Google Scholar 

  • Stremmel W (1992) Pathogenese des M. Wilson. Z Gastroenterol 30: 199–205

    CAS  Google Scholar 

  • Walshe JM (1982) Treatment of Wilson’s disease with trientine (Triethylene tetramine) dihy-drochloride. Lancet 1: 643–647

    Article  PubMed  CAS  Google Scholar 

  • Wilson K (1912) Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain 16: 295–509

    Article  Google Scholar 

  • Crystal RG (1990) Alpha!-antitrypsin deficiency, emphysema and liver disease: genetic basis and strategy for therapy. J Clin Invest 85: 1343–1348

    Article  PubMed  CAS  Google Scholar 

  • Elzouki AN, Eriksonn S (1996) Risk of hepatobiliary disease in adults with severe ai-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? Europ J Gastroenterol Hepatol 8: 989–994

    Article  CAS  Google Scholar 

  • Gerok W, Häussinger D, Pausch J (1995) Primäre Stoffwechsel- und Speichererkrankungen der Leber. In: Gerok W und Blum HE (Hrsg) Hepatologie. Urban & Schwarzenberg, München, S 508–544

    Google Scholar 

  • Lombard M, Mieli-Vergani G (1995) Haemochromatosis, Wilson’s disease and hepatic enzyme defects in adults. In: Williams R, Portman B, Tan KC (Hrsg) The practice of liver tansplantation. Churchill Livingstone, London, S 73–81

    Google Scholar 

  • Pelmutter DH (1991) The cellular basis for liver injury in alphai-antitrypsin deficiency. He- patology 13: 172–176

    Google Scholar 

  • v. Schönfeld J, Breuer N (1993) ai-Antitrypsin-Mangel und Erkrankungen der Leber. Dtsch Med Wochenschr 118: 1819–1824

    Google Scholar 

  • Schwarzenberger SJ, Sharp HL (1993) α1-antitrypsin deficiency. In: Schiff L und Schiff ER (Hrsg) Diseases of the liver, 7th edn. JB Lippincott Company, Philadelphia, S 692–706

    Google Scholar 

  • Balistreri WF (1997) Bile acid therapy in pediatric hepatobiliary disease: the role of urso-deoxycholic acid. J Pediatr Gastroenterol Nutr 24: 573–589

    Article  PubMed  CAS  Google Scholar 

  • Bargon J, Sanders S, Caspary WF, Buhl R (1995) Therapie der zystischen Fibrose im Erwachsenenalter - Gegenwart und Zukunft. Pneumologie 49: 573–583

    PubMed  CAS  Google Scholar 

  • Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A (1990) Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatrics 117: 482–489

    Article  CAS  Google Scholar 

  • Colombo C, Battezzati PM (1996) Hepatobiliary manifestations of cystic fibrosis. Europ J Gastroenterol Hepatol 8: 748–754

    CAS  Google Scholar 

  • Colombo C, Battezzati P M, Podda M, Bettinardi N, Giunta A and the Italian Group for the Study of Ursodeoxycholic acid in Cystic Fibrosis (1996) Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. Hepatology 23: 1484–1490

    Article  Google Scholar 

  • Cotting J, Lentze MJ, Reichen J (1990) Effects of ursodeoxycholic acid treatment on nutrition and life function in patients with cystic fibrosis and longstanding cholestasis. Gut 31: 918–921

    Article  PubMed  CAS  Google Scholar 

  • Noble-Jamieson G, Valente J, Barnes ND, Friend PJ, Jamieson NV, Rasmussen A et al. (1994) Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Child 71: 349–352

    Article  PubMed  CAS  Google Scholar 

  • Smith LJ, Lacaille F, Lepage G, Ronco N, Lamarre A, Roy CC (1991) Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial. Am J Dis Child 145: 1401–1404

    Google Scholar 

  • Stern RC (1994) Cystic fibrosis and the gastrointestinal tract. In: Davis P (Hrsg) Cystic fibrosis. Mercel Dekker Inc, New York, S 401–426

    Google Scholar 

  • Westaby D (1995) Liver and biliary disease im cystic fibrosis. In: Hodson ME, Geddes DM (Hrsg) Cystic fibrosis. Chapman and Hall Medical, London, S 281–293

    Google Scholar 

  • Assmann G, Frederickson DS (1983) Acid lipase deficiency: Wolmans’ disease and cholesteryl ester storage disease. In: Stanbury JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS (Hrsg) The metabolic basis of inherited diseases. 5th edn. McGraw Hill Book Co, New York, S 803–819

    Google Scholar 

  • Barton NW, Brady RO, Dambrosia JM et al. (1991) Replacement therapy for inherited en¬zyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med 324: 1464–1470

    Article  PubMed  CAS  Google Scholar 

  • Batshaw ML (1984) Long-term treatment of inborn errors of urea synthesis. In: Kleinberger G, Ferenci P, Riederer P, Thaler H (Hrsg) Advances in hepatic encephalopathy and urea cycle disease. Karger, Basel, S 187–195

    Google Scholar 

  • Beutler E (1991) Gaucher’s disease. N Engl J Med 325: 1354–1369

    Article  PubMed  CAS  Google Scholar 

  • Di Bisceglie AM, Ishak KG, Rabin L, Hoeg IM (1990) Cholesteryl ester storage disease: Hepatopathology and effects of therapy with lovastatin. Hepatology 11: 764–772

    Google Scholar 

  • DuCerf C, Bancel B, Caillon P, Adham M, Guibaud P, Spay G, Pouyet M (1992) Orthotopic liver transplantation for type 1 Gaucher’s disease. Transplantation 53: 1141–1143

    Article  PubMed  CAS  Google Scholar 

  • Gerok W, Häussinger D, Pausch J (1995) Primäre Stoffwechsel- und Speicherkrankheiten der Leber. In: Gerok W, Blum HE (Hrsg) Hepatologie. Urban & Schwarzenberg, München, S 513–518

    Google Scholar 

  • Gitzelmann R, Steinemann B, van den Berghe G (1983) Essential fructosuria, hereditary fructose intolerance, and fructose-l,6-diphosphatase deficiency. In: Stanbury JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS (Hrsg) The metabolic basis of in-herited diseases. 5th edn. McGraw Hill Book Co, New York, S 118–140

    Google Scholar 

  • Segal S (1983) Disorders of Galactose metabolism. In: Stanbury IB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS (Hrsg) The metabolic basis of inherited diseases, 5th edn. McGraw Hill Book Co, New York, S 167–191

    Google Scholar 

  • Smanik EJ, Tavill AS, lacobs GH, Schafer IA, et al. (1993) Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher’s diseases: implications for the treatment of inherited metabolic disease. Hepatology 17: 42–49

    Article  PubMed  CAS  Google Scholar 

  • Starzl TE, Demetris AJ, Trucco M et al. (1993) Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher’s disease. N Engl I Med 328: 745–749

    Article  CAS  Google Scholar 

  • Zimran A, Sorge J, Gross E (1989) Prediction of severity of Gaucher’s disease by identification of mutations at DNA level. Lancet 1989, 11: 349–352

    Article  Google Scholar 

  • Bloomer JR, Straka JG, Rank JM (1993) The porphyrias. In: Schiff L, Schiff ER (eds) Diseases of the liver. Philadelphia, S 1438–1464

    Google Scholar 

  • Doss MO (1995) Porphyrie. In: Thomas L (Hrsg) Labor und Diagnose. Marburg, S 549–560

    Google Scholar 

  • Doss MO, Frank M (1989) Hepatobiliary implications and complications in protoporphyria: a 20-year study. J Clin Biochem 22: 223–229

    Article  CAS  Google Scholar 

  • Gerok W, Häussinger D, Pausch J (1995) Primäre Stoffwechsel- und Speicherkrankheiten der Leber. In: Gerok W, Blum HE (Hrsg) Hepatologie. Urban & Schwarzenberg, München, S 508–544

    Google Scholar 

  • Köstler E, Doss MO (1993) Die chronische hepatische Porphyrie. Erg Inn Med Kinderh 61: 123–205

    PubMed  Google Scholar 

  • Köstler E, Doss MO (1995) Porphyria cutanea tarda (chronische hepatische Porphyrie). Dtsch Med Wochenschr 120: 1405–1410

    Article  PubMed  Google Scholar 

  • Berk PD, Jones EA, Howe RB (1979) Bilirubin metabolism. In: Bondy PK, Rosenberg L (Hrsg) Metabolie disease and control, 8th edn. WB Saunders, Philadelphia, S 1009–1088

    Google Scholar 

  • Bosma PJ, Goldhoon B, Oude-Elferink RPJ, Sinaa-Sappel M, Oostra BA, Jansen PLM (1993) A mutation in bilirubin uridine 5’-diphosphate-glucoronyltansferase isoform I causing Crigler-Najjar syndrome II. Gastroenterology 105: 216–220

    PubMed  CAS  Google Scholar 

  • Bosma PJ, Chowdhury JR, Bakker C et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucoronyltransferase 1 in Gilbert’s syndrome. N Engl J Med 333: 1171–1175

    Article  PubMed  CAS  Google Scholar 

  • Gerok W (1995) Ikterus. In: Gerok W, Blum HE (Hrsg) Hepatologie. Urban & Schwarzenberg, München, S 230–245

    Google Scholar 

  • Ritter JK, Yeatman MT, Ferreira P, Owens IS (1992) Identification of a genetic alteration in the code for bilirubin UDP-glucuronyltransferase in the UGT1 gene complex of a Crig- ler-Najjar type I patient. J Clin Invest 90: 150–155

    Article  PubMed  CAS  Google Scholar 

  • Roy-Chaudury J, Roy-Chaudury N (1993) Unveiling the mysteries of inherited disorders of bilirubin glucuronidation. Gastroenterology 105: 288–293

    Google Scholar 

  • Schmid R (1995) Gilbert’s syndrome - a legitimate genetic anomaly? N Engl J Med 333: 1217–1218

    Article  PubMed  CAS  Google Scholar 

  • Zimniak P (1993) Dubin-Johnson and Rotor syndromes: Molecular basis and pathogenesis. Sem Liver Dis 13: 248–260

    Article  CAS  Google Scholar 

  • Bass NM, Ockner RK (1996) Drug induced liver disease. In: Zakim D, Boyer TD (Hrsg) Hepatology. A textbook of liver disease, 3rd edn. WB Saunders, Philadelphia, S 962–1017

    Google Scholar 

  • Christensen E, Gluud C (1995) Glucocorticoids are ineffective in alcoholic hepatitis: a me-taanalysis adjusting for confounding variables. Gut 37: 113–118

    Article  PubMed  CAS  Google Scholar 

  • Consensus Meeting (1990) Criteria of drug-induced liver disorders. J Hepatol 11: 272–276

    Google Scholar 

  • Dancygier H (1987) Klinische Pharmakologie der Leberkrankheiten. In: Kuemmerle HP (Hrsg) Klinische Pharmakologie, 4. Aufl. IV-4.11.1, ecomed, S 1 - 34

    Google Scholar 

  • Dancygier H (1990) Alkoholische Lebererkrankungen. Krankenhausarzt 63: 670–674

    Google Scholar 

  • Farrell GC (1994) Drug induced liver disease. Churchill Livingstone, Edinburgh

    Google Scholar 

  • Kearns PI, Youno H, Garcia G et al. (1992) Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 100: 200–205

    Google Scholar 

  • Kluge F (1995) Leberschäden durch Fremdstoffe. In: Gerok W, Blum HE (Hrsg.) Hepatologie, 2 Aufl. Urban & Schwarzenberg, München, S 463–480

    Google Scholar 

  • Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med. 333:1118–1127 Lieber CS (1994) Alcohol and the liver: 1994 update. Gastroenterology 106: 1085–1105

    Google Scholar 

  • Lipp HP, Schuler U (1995) Die menschlichen Cytochrom-P 450-Isoenzyme. Arzneimitteltherapie 13: 272–280

    Google Scholar 

  • Mathurin P, Duchatelle V, Ramond MJ et al. (1996) Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110: 1847–1853

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman HJ, Maddrey WC (1995) Acetaminophen (Paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventures. Hepatology 22: 767–773

    Article  PubMed  CAS  Google Scholar 

  • Ahn SS, Yellin A, Sheng FC, Colonna JO, Goldstein LI, Busuttil RW (1987) Selective surgical therapy of the Budd-Chiari-syndrome provides superior survivor rates than conservative medical management. J Vase Surg 5: 28–37

    CAS  Google Scholar 

  • Al Karawi MA, Quiz M, Clark D, Hilali A, Mohamed AE, Jawdat M (1990) Mesenteric vein thrombosis, non-invasive diagnosis and follow-up ( US + MRI), and non-invasive therapy by streptokinase and anticoagulants. Hepatogastroenterolgy 37: 507–509

    Google Scholar 

  • Baert AL, Fevery J, Marchai G, Goodeeris P, Wilms G, Ponette E, De Groote J (1983) Early diagnosis of Budd-Chiari-Syndrome by computed tomography and ultrasonography: Report of five cases. Gastroenterology 84: 587–595

    Google Scholar 

  • Bismuth E, Hadenque A, Hammel P, Benhamou JP (1990) Hepatic vein thrombosis in Behcet’s disease. Hepatology 11: 969–974

    Article  PubMed  CAS  Google Scholar 

  • Chamberlain DW, Walter JB (1969) The relationship of Budd-Chiari-syndrome to oral contraceptives and trauma. Can Med Assoc J 101: 97–102

    PubMed  CAS  Google Scholar 

  • Conn HO (1993) Transjugular intrahepatic portal-systemic shunts. The state of the art. Hepatology 17: 148–158

    Article  PubMed  CAS  Google Scholar 

  • Dahm JB, Riebeling VM (1993) Thrombolyse einer septischen Pfortaderthrombose mit ultrahochdosierter Streptokinase. Dtsch Med Wochenschr 118: 582–586

    Article  PubMed  CAS  Google Scholar 

  • Fidler H, Booth A, Hodgson HJF, Calam J, Luzatto L, Hughes JMB (1990) Portal vein thrombosis in myeloproliferative disease. Brit Med 300: 590–592

    Article  CAS  Google Scholar 

  • Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE (1990) Liver transplantation for the Budd-Chiari-syndrome. Ann Surg 211: 43–50

    Article  PubMed  CAS  Google Scholar 

  • Jäger D, Hüppe D, Weber A, Schwegler U, Barth J, Braun BE (1994) Pfortaderthrombose bei Protein-C-Mangel: Erfolgreiche Fibrinolysetherapie mittels ultrahochdosierter Streptokinase. Med Klin 89: 453–455

    Google Scholar 

  • Klein AS, Sitzman JV, Coleman J, Herlong FH, Cameron JL (1990) Current management of the Budd-Chiari-syndrome. Ann Surg 212: 144–148

    Article  PubMed  CAS  Google Scholar 

  • Kreisel W, Walter E, Gerok W (1990) Die nicht zirrhotisch bedingte portale Hypertonie. Z Gastroenterol 28: 578–583

    PubMed  CAS  Google Scholar 

  • Mann O, Haag K, Hauenstein KH, Rössle M, Pausch J (1995) Septische Pfortaderthrombose. Erfolgreiche Therapie durch lokale Fibrinolyse und transjugulären portosystemischen Stent-Shunt ( TIPS ). Dtsch Med Wochenschr 120: 1201–1206

    Google Scholar 

  • Michaeli D, Benbessat I, Miller H, Deursch V (1968) Hepatic telangiectasia and porto-systemic encephalopathy in Rendu-Osler-Weber disease. Gastroenterology 54: 906–932

    Google Scholar 

  • Mies S, Alfieri F, Fischer Chamone D, Raia S (1991) Portal vein thrombosis repermeabilisation with r-tPA. Thrombos Haemost 65: 108

    CAS  Google Scholar 

  • Ohnishi K, Terabayashi H, Tsunoda T, Nomura F (1990) Budd-Chiari-syndrome: diagnosis with duplex sonography. Am J Gastroenterol 85: 165–169

    PubMed  CAS  Google Scholar 

  • Osler W (1901) On a familiary form of recurring epistaxis associated with multiple telangiectasias of the skin and mucous membranes. Bull Johns Hopk Hosp 12: 333–337

    Google Scholar 

  • Ouchi K, Matsubara S, Mikuni J, Katayose Y, Endo K, Matsuno S (1994) The radiologic presentation of Osier-Weber-Rendu disease of the liver. Am J Gastroenterol 89: 425–428

    PubMed  CAS  Google Scholar 

  • Paquet KJ, Raschke E, Popov S, Bücheler E (1971) The fibrinolytic therapy of thrombosed portal veins and shunts in liver cirrhosis with portal hypertension and in prehepatic block. J Cardiovasc Surg 12: 147–151

    CAS  Google Scholar 

  • Popp J, Wagner A (1990) Erfolgreiche Thrombolyse bei Pfortaderthrombose. Münch Med Wschr 132: 784–786

    Google Scholar 

  • Radosevich PM, Ring EJ, LaBerge JM, Peltzer MY, Haskai ZJ, Doherty MM, Gordon RL (1993) Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 186: 523–527

    PubMed  CAS  Google Scholar 

  • Ralls PW (1990) Colour Doppler sonography of the hepatic artery and portal venous system. Amer J Roentgenol 155: 517–525

    CAS  Google Scholar 

  • Reynolds TB (1993) Budd Chiari-syndrome. In: Schiff L, Schiff ER (Hrsg) Diseases of the liver, 7th edn. JB Lippincott, Philadelphia, S 1091–1098

    Google Scholar 

  • Rössle M, Haag K, Ochs A et al. (1994) The transjugular intrahepatic portosystemic stent-shunt. N Engl J Med 330: 165–171

    Article  PubMed  Google Scholar 

  • Sherlock S, Gooley J (1993) Diseases of the liver and biliary system. 9th edn. Blackwell Scientific Publications, S 336–337

    Google Scholar 

  • Shulman HM, Gown AM, Nugent DJ (1987) Hepatic veno-occlusive disease after bone marrow transplantation. Am J Pathol 127: 549–550

    PubMed  CAS  Google Scholar 

  • Stuart KL, Bras G (1957) Veno-occlusive disease of the liver. Q J Med 26: 291–296

    PubMed  CAS  Google Scholar 

  • Uflacker R, Alves MA, Cantisani GG, Souza HP, Wagner J, Moraes LF (1985) Treatment of portal vein thrombosis by percutaneous transhepatic angioplasty. Gastroenterology 88: 176–180

    PubMed  CAS  Google Scholar 

  • Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benham JP (1986) Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study. Gastroenterology 90: 807–811

    PubMed  CAS  Google Scholar 

  • Webb LJ, Sherlock S (1979) The aetiology, presentation and natural history of extrahepatic portal venous obstruction. Quart J Med 48: 627–632

    PubMed  CAS  Google Scholar 

  • Benhamou JP, Lebrec D, Hadengue A (1995) Pulmonary arterial hypertension in patients with portal hypertension. In: Holstege A, Hahn EG, Schölmerich J (Hrsg) Portal Hypertension. Kluwer Academic Publishers Dordrecht, Boston London, S 178–192

    Google Scholar 

  • Böker KHW, Welte T (1995) Lungenbeteiligung bei Lebererkrankungen. Dtsch Med Wochenschr 120: 1053–1056

    Article  PubMed  Google Scholar 

  • Eriksson LS, Södermann C, Ericzon BG, Eleborg L, Wahen J, Hedenstierna G (1990) Normalization of ventilation/perfusion relationship after liver tansplantation in patients with decompensated liver cirrhosis. Evidence for a hepatopulmonary syndrome. Hepatology 12: 1350–1357

    Google Scholar 

  • Rich S, Kaufmann E, Levy PS (1992) The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327: 76–81

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Roisin R, Agusti AGN, Roca J (1992) The hepatopulmonary syndrome: new name, old complexities. Thorax 47: 897–902

    Article  PubMed  CAS  Google Scholar 

  • Sherlock S (1993) Hepato-cellular failure. In: Sherlock S (Hrsg) Diseases of the liver and the biliary system, 9th edn. Blackwell Scientific Publishers, Oxford, S 50–86

    Google Scholar 

  • Wettstein M, Häussinger D (1995) Leber und Lunge. In: Gerok W, Blum HE (Hrsg) Hepato- logie. Urban & Schwarzenberg, München, S 728–737

    Google Scholar 

  • Alarcon-Segovia D, Diaz-Jounanen E, Fishbein E (1973) Features of Sjogrens’s syndrome in primary biliary cirrhosis. Ann Intern Med 79: 31–36

    PubMed  CAS  Google Scholar 

  • Bron KM, Gajaraj A (1970) Demonstration of hepatic aneurysm in polyarteritis nodosa by arteriography. N Engl J Med 282: 1024–1025

    Article  PubMed  CAS  Google Scholar 

  • Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER (1982) Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 57: 365–370

    PubMed  CAS  Google Scholar 

  • Fried MW, Di Bisceglie AM (1993) Metabolic diseases of the liver. In: Rustgi VK, Van Thiel DH (Hrsg) The liver in systemic disease. Raven Press, Ltd, New York, S 167–189

    Google Scholar 

  • Gardner F, Stewart A, Mac Callum FO (1945) Therapeutic effect of induced jaundice in rheumatoid arthritis. Br Med J 2: 677–680

    Article  Google Scholar 

  • Gertz MA, Kyle RA (1988) Hepatic amyloidosis (primary [AL], immunoglobulin light chain); The natural history in 80 patients. Am J Med 85: 73–80

    Article  PubMed  CAS  Google Scholar 

  • Gertz MA, Kyle RA (1989) Primary systemic amyloidosis - a diagnostic primer. Mayo Clin Proc 64: 1505–1519

    PubMed  CAS  Google Scholar 

  • Gurian LE, Rogoff TM, Ware AJ, Jordan RE, Combes B, Gilliam JN (1985) The immunologic diagnosis of chronic active “autoimmune” hepatitis: distinction from systemic lupus erythematosus. Hepatology 5: 397–402

    Article  PubMed  CAS  Google Scholar 

  • Kowdley KV, Kaplan MM (1993) The liver in collagen-vascular diseases. In: Rustgi VK, Van Thiel DH (Hrsg) The liver in systemic disease. Raven Press, Ltd, New York, S 43–60

    Google Scholar 

  • Lowe JR, Pickup ME, Dixon JS, Leatham PA, Rhind VM, Wright V, Downie WW (1978) Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis 37: 428–431

    Article  PubMed  CAS  Google Scholar 

  • Mills PR, Sturrock RD (1982) Clinical association between arthritis and liver disease. Ann Rheum Dis 41: 295–307

    Article  PubMed  CAS  Google Scholar 

  • Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ (1984) Sclerosing cholangitis, chronic pancreatitis, and Sjögrens’ syndrome: a syndrome complex. Am J Surg 147: 822–826

    Article  PubMed  CAS  Google Scholar 

  • Rau R, Karger T, Herborn G, Frenzel H (1989) Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. J Rheumatol 16:489– 493

    Google Scholar 

  • Spooner RJ, Smith DH, Bedford D, Beck PR (1982) Serum gamma-glutamyltransferase and alkaline phosphate in rheumatoid arthritis. J Clin Pathol 35: 638–642

    Article  PubMed  CAS  Google Scholar 

  • Thorne C, Urowitz MB, Wanless I, Roberts E, Blendis LM (1982) Liver disease in Felty’s syndrome. Am J Med 73: 35–40

    Article  PubMed  CAS  Google Scholar 

  • Carr JM (1989) Disseminated intravascular coagulation in cirrhosis. Hepatology 10: 103–110

    Article  PubMed  CAS  Google Scholar 

  • Erslev AJ (1994) The hemopoietic functions of the liver. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA (Hrsg) The liver: biology and pathobiology, 3rd edn. Raven Press, New York, pp 1227–1234

    Google Scholar 

  • Gerok W (1995) Leber, hämatopoetisches System und Hämostasesystem. In: Gerok W, Blum HE (Hrsg) Hepatologie, 2. Aufl. Urban & Schwarzenberg, München, S 810–814

    Google Scholar 

  • Lindenbaum J (1987) Hematologic complications of alcohol abuse. Sem Live Dis 7: 169–181

    Article  CAS  Google Scholar 

  • Paramo JA; Rocha E (1993) Hemostasis in advanced liver disease. Sem Thrombos Hemostas 19: 184–190

    Article  PubMed  CAS  Google Scholar 

  • Sherlock S, Gooley J (1993) Diseases of the liver and biliary system, 9th edn. Blackwell Scientific Publications, Oxford, London, pp 44–61

    Google Scholar 

  • Balan V, Raketla J. (1996) Pregnancy after liver transplantation. In: Reyes HB, Leuschner U, Arias IM (Hrsg) Pregnancy, sex hormones and the liver. Kluwer, Dordrecht Boston Lon-don, S 295–300

    Google Scholar 

  • Bourget P, Fernandez H et al. (1993) Pharmacokinetics of cyclosporin A during pregnancy; monitoring of treatment and specific arrays of cyclosporin, based on five liver transplant patients. J Pharm Biomed Anal 11: 43–48

    Article  PubMed  CAS  Google Scholar 

  • Huchzermeyer H (1978) Leber und Schwangerschaft. Huber, Bern Stuttgart Wien

    Google Scholar 

  • Kirsch RE, Harris V, Hift RJ, Meissner PN et al. (1996) Pregnancy in chronic liver disease. In: Reyes HB, Leuschner U, Arias I M (Hrsg) Pregnancy, sex hormones and the liver. Kluwer, Dordrecht Boston London, S 165–176

    Google Scholar 

  • Laifer SA, Guido RS (1995) Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 70: 388–394

    Article  PubMed  CAS  Google Scholar 

  • Palma J, Reyes H, Ribalta J et al. (1996) Ursodeoxycholic acid therapy in cholestasis of pregnancy. In: Reyes HB, Leuschner U, Arias IM (Hrsg) Pregnancy, sex hormones and the liver. Kluwer, Dordrecht Boston London, S 223–229

    Google Scholar 

  • Sherlock S. (1996) Acute fatty liver of pregnancy. In: Reyes HB, Leuschner U, Arias IM (Hrsg) Pregnancy, sex hormones and the liver. Kluwer, Dordrecht Boston London, S 202–208

    Google Scholar 

Download references

Authors
  1. S. Zeuzem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Lembcke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Leuschner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Teuber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. F. Caspary
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. P. Kaltwasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Bargon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. F. Dietrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. W. Sahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. Güldütuna
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Danzygier
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R. Buhl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum der Inneren Medizin Medizinische Klinik II, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Deutschland

    Wolfgang F. Caspary , Ulrich Leuschner  & Stefan Zeuzem ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zeuzem, S. et al. (1997). Krankheiten der Leber. In: Caspary, W.F., Leuschner, U., Zeuzem, S. (eds) Therapie von Leber- und Gallekrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97978-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97978-1_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97979-8

  • Online ISBN: 978-3-642-97978-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation